Gynecologic Oncology

Gynecologic Oncology

Specialize in providing a personalized approach to cancer care.

Broward Health’s gynecologic oncology division offers a dedicated team of caregivers who are committed to providing high-quality care to all women with gynecologic malignancies. We treat a wide spectrum of complex gynecologic surgical conditions, such as fibroids, endometriosis, and ovarian masses.

We specialize in providing a personalized approach to cancer care. Our providers offer extensive counseling, ensuring that all questions are answered during the shared decision-making process with patients. Together, we will decide on the correct surgical approach (laparoscopic, robotic, or open) and the optimal chemotherapy plan (if needed) pre- or post-operatively. We also work closely with the Department of Radiation Oncology to offer comprehensive cancer care.

For more information about our gynecological oncology services, please call 954.355.4345. For information on clinical trials, please click here

Every patient and every cancer are different. We utilize both germline genetic testing and tumor tissue testing to determine the best possible therapy for each patient. These testing results not only impact treatment decisions but may also lead to recommendations for cascade testing of patient family members by our genetic counseling staff.

Our wide portfolio of research trials that are available to our patients ensures that cutting-edge, experimental therapies are often available as an alternative to standard treatments. We welcome consultations for second and third opinions, no matter where cancer treatment was initiated.

We discuss treatment options in our weekly Multidisciplinary Disposition Conference with all members of our team, including gynecologic oncologists, radiation oncologists, radiologists, pathologists, and research staff. This collaborative method results in thorough and well-rounded care for our patients and their loved ones during treatment and into survivorship.

Cancers We Treat:

Cervical cancer: While cervical cancer is the most common gynecologic malignancy worldwide, widespread pap screening and expeditious treatment of precancerous lesions have made it the third most common gynecologic malignancy reported in the United States. Very early cervical cancer is treated surgically by hysterectomy, often by a minimally invasive (robotic) approach. Slightly larger cervical cancer tumors require a radical hysterectomy, usually using a “bikini cut” incision similar to a C-section. Fertility-sparing options are available for both surgeries. If the tumor is too large to be treated surgically, radiation therapy and chemotherapy are required. Even if the tumor is inoperable, early-stage cervical cancers are often curable.

Gestational Trophoblastic Neoplasia: This rare class of gynecologic malignancies begins in the pregnancy tissue (often in the placenta) and is profoundly sensitive to chemotherapy. The vast majority of patients treated for GTN will achieve complete remission and will not recur.

Ovarian/Fallopian tube/Primary peritoneal cancers: Affecting nearly 22,000 women annually in the United States, ovarian cancer has traditionally been considered the deadliest gynecologic cancer. However, recent advances in targeted therapy have drastically improved the ovarian cancer prognosis for many women. Since this cancer is the result of targetable genetic mutations up to 50 percent of the time, it is vital to obtain genetic testing as soon as possible after diagnosis. Treatment usually consists of surgical removal of all tumor implants in the abdominal cavity in combination with chemotherapy. Once the cancer is in remission, there is often an option for maintenance therapy to prevent a recurrence.

Uterine cancers: Endometrial cancer is the most common type of uterine cancer and is the most common gynecologic malignancy in the United States, with over 65,000 new cases per year. Uterine cancer is often diagnosed early due to the presence of postmenopausal bleeding. It is treated primarily by surgical removal of the uterus, fallopian tubes, and ovaries, often by a minimally invasive approach, such as robotic surgery. Robotic surgery allows for evaluation of the sentinel lymph nodes, which is the first place uterine cancer often metastasizes to, without requiring removal of all of the pelvic lymph nodes. This substantially lowers the risk of postoperative lymphedema. Some patients may require postoperative radiation, and possibly chemotherapy, but many patients are completely treated with surgery alone.

Uterine Sarcoma: Uterine sarcomas, such as leiomyosarcoma, are often diagnosed unexpectedly following surgery for fibroids in the early stages. Advanced stage disease requires additional aggressive treatment with chemotherapy. Due to the aggressive nature of this disease, a personalized approach to treatment is vital.

Vaginal and vulvar cancer: These cancers are rarer than cervical cancer, but are often treated similarly, with either surgical resection of the affected vagina or vulva, evaluation of the groin lymph nodes, and possible postoperative radiation.

Find a Doctor

We can match you to a doctor based on your location, language preference, and more. The search results will provide more ways to narrow your search.

Available At